[ad_1] RT @ThomasCiullaMD: Given recent clinical trial results in geographic atrophy/dry AMD, there has been great interest in our review of compl… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @RevOphth: Therapeutics in the Suprachoroidal Space — A look at different approaches companies are taking to make use of this unique as… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Thanks to Keith Barton, Kuldev Singh, Bart Leroy & Dominik Fischer for inviting me to participate in the Ophthalmology Futures European Retina Forum 2021, featuring interesting panel sessions & presentations on therapeutic innovation!
#eyes #retina #retinaspecialist #biotech https://t.co/qEUiQYX1tk
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Honored to be interviewed for this piece on the Business of Medicine MBA, an unique program for physicians, offered by Indiana University’s Kelley School of Business, a highly ranked MBA program… https://t.co/VOqnkBnSpf [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ELS_Ophthal: Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema @AAOjournal https://t.co/rof9cYXLvf https://t… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Thanks to Arshad M. Khanani, Charles Wykoff, Jeff Heier and Peter Kaiser for inviting me to the Clinical Trials at the Summit meeting, which was terrific!
#eyes #retina #retinaspecialist #biotech https://t.co/EtFZRtmBya
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @IllinoisRetina: Dr. Merrill’s article “Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Just published: “Delivery of Genetic Information: Viral Vector and Nonviral Vector Gene Therapies”: International Ophthalmology Clinics #eye #retina #GeneTherapy #biotech https://t.co/8magRHLy0c [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published on a potential therapy for uveitic macular edema. A clinically meaningful benefit of suprachoroidal CLS-TA was noted in uveitic macular edema patients, regardless of concurrent systemic therapy usage.
#eye #retina #suprachoroidal #uveitis
https://t.co/GlDzS810GS
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Diurnal optic nerve head blood flow biomarker differences between male and female subjects with and without glaucoma measured by optical coherence tomography angiography | IOVS | ARVO Journals https://t.co/7S71nbCs3S [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.